Navigation Links
Resistant Influenza strains creates panic in US

Rick A. Bright, an immunologist at the U.S. Centers for Disease Control and Prevention said that all samples of seasonal influenza virus this year have developed // resistance to adamantanes, the class of drugs which is used for the treatment for flu infection.

Drugs belonging to this class like amantadine and rimantadine are ineffectual for now and for the foreseeable future and shouldn't be used.

The findings were reported in the Journal of the American Medical Association. Amantadine and rimantadine were the pivotal drugs used against influenza A.

Statistics show that about 10-15% of the U.S. population suffers due to flu every year, and about 31,000 people die of it. Vaccination is considered the best strategy to prevent infection.

It was found that 91% of the 120 influenza a virus samples that were tested were resistant to these two drugs.

Presently a total of 209 influenza isolates (including the original 120) from 26 states across the United States were collected and analyzed. Overall resistance was found to be 92 %.

The researchers were very surprised at the speed with which the influenza strains develop the resistance. They feel that this is due to the widespread, over-the-counter and unregulated use of the drugs in other countries.

Tamiflu (oseltamivir) and Relenza (zanamivir) both the antiviral drugs belong to the neuraminidase inhibitor class of antivirals. The virus has not developed resistance against this class of drugs and hence can be used. But researchers fear that people will be using them more and might begin using them inappropriately and, with increased and inappropriate use, this will also become ineffective against the virus.

The researchers feel that there is an increased necessity for more energy and resources to be devoted to develop new antiviral drugs. In the end they conclude by saying that vaccines are the true way to protect oneself against influenz
'"/>




Page: 1 2

Related medicine news :

1. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
2. Hope for Chemo-Resistant Leukemia Patients
3. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
4. HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A Second Epidemic
5. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
6. Treatment Resistant Tumors Can Be Targeted Better Using Botox
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. ‘Drug Resistant TB’ Rattles the Union Ministy
9. Malaria Resistant Mosquitoes Could Help In Combating Malaria
10. Tumor Resistant Mice Point To Novel Cancer Treatments
11. Mad-Cow Resistant Calf Cloned in China

Post Your Comments:
(Date:11/27/2009)...v. 27 Team Garmin-Slipstream, the ... to ethical sporting and developing the next gener...t will become Team Garmin-Transitions with the add...he team. Transitions Optical is the world,s leadin...ost advanced photochromic technology in the widest...
(Date:11/27/2009)...les may reduce future disease burden, researchers ... -- Encouraging city dwellers to walk and bicycle ...lic health benefits than increased used of low-emi...The study compared the projected health effects in...s for London, England, and Delhi, India: business...
(Date:11/27/2009)...de; announced today that Spectrum Health (Grand Ra...ise orthopedic templating solution and its TraumaC... (PRWEB) November 27, 2009 -- Voyant Health&t...Rapids, Michigan) has licensed its TraumaCad Enter...aCad Extend workflow solution, to allow its orthop...
(Date:11/27/2009)...tive anatomy education apps from Modality and Lipp...es learning opportunities for iPhone and iPod touc...vember 27, 2009 -- Modality, Inc. and Lippincott...rs Kluwer Health, today announced the availability...ore. Clemente’s Anatomy, Rohen’s Photo...
(Date:11/26/2009)...cans living with diabetes will nearly double, incr...n 2034. Over the same period, spending on diabetes...336 billion, even with no increase in the prevalen... of Chicago report in the December issue of Diabe...overed by Medicare will rise from 8.2 million to 1...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...ielman, M.D, Duke University Medical Center to sho...ting HIV infections than those which charge a smal...he testing center and is therefore a very efficien...the testing centre were 4 per day but after the fr...
... Internet and e-mail contribute towards strengthen...is has been revealed by the Pew Internet and Ameri...social relations get affected as a result of the I... in those networks do not live close to them, a Pe...
...ndian Government to produce some films with the Na...ht the achievements of Indian Scientists, //in add... in science. The name of the new initiative of the... The films will focus on nano-technology, the s...
...icist at the Max-Planck Institute for Dynamics and...which helped the researchers to understand the spr...s with the help of money trials.// He tracked...scientist fight against easily transmissible disea...
... common cancer next to breast cancer in women and ...y recognisation of cervical cancer would help in e...tality due to cervical cancer. A cytologic screeni...above the age of 18 years require yearly Pap smear...
...tion (APA) has released tips to help prevent the b...ion during the National Heart Month.// Research ha...ess will have an adverse impact on their health an... in effective ways that don't at the same time tak...
Other Medicine News:Health News:Free HIV Tests Brings Crowd to the Testing Centers 2Health News:Tracking the spread of disease with the help of money 2
(Date:11/25/2009)...Newswire/ -- BioTrends Research Group, Inc. releas... report, the first in a multi-phase syndicated mar...or Ortho-Biotech,s Stelara, from product launch th...wave of the report provides quantitative informati...nformation from a subset of 20. The reports asses...
(Date:11/25/2009)...v. 25 Regado Biosciences, a privat...rombotic aptamers with active control agents, anno...ll be presenting at the Piper Jaffray 21st Annual ...l in New York City. Dr. Mazzo,s presentation will...nd will include an overview of the Company,s pipel...
(Date:11/25/2009)... Nov. 25 Swissray International, I...graphy ( ddR ) systems, announced today that its o...vestor with a long term view towards growing Swiss...ded all assets and intellectual property, as well ...ess and growth Swissray is now poised to move to t...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Cardiac Science Announces Third Quarter Results 6112 1Cardiac Science Announces Third Quarter Results 6112 2Cardiac Science Announces Third Quarter Results 6112 3Cardiac Science Announces Third Quarter Results 6112 4Cardiac Science Announces Third Quarter Results 6112 5Cardiac Science Announces Third Quarter Results 6112 6Cardiac Science Announces Third Quarter Results 6112 7Cardiac Science Announces Third Quarter Results 6112 8Cardiac Science Announces Third Quarter Results 6112 9Cardiac Science Announces Third Quarter Results 6112 10Cardiac Science Announces Third Quarter Results 6112 11Cardiac Science Announces Third Quarter Results 6112 12Cardiac Science Announces Third Quarter Results 6112 13Cardiac Science Announces Third Quarter Results 6112 14Cardiac Science Announces Third Quarter Results 6112 15Cardiac Science Announces Third Quarter Results 6112 16Cardiac Science Announces Third Quarter Results 6112 17Cardiac Science Announces Third Quarter Results 6112 18Cardiac Science Announces Third Quarter Results 6112 19Cardiac Science Announces Third Quarter Results 6112 20Forecast Looks Good for India Pharma Shows 6107 1Forecast Looks Good for India Pharma Shows 6107 2Forecast Looks Good for India Pharma Shows 6107 3Stipkala LLC to Sponsor Texas Life Science Conference November 12 13 2009 6102 1
...E PARK, N.C.--(BUSINESS WIRE)--Apr 3, 2007 -,Icage...ing a,planned meeting of the independent Data Moni...rial of senicapoc (formerly,ICA-17043) for the tre...ecommended that the trial be terminated because of...risis rate, the primary,endpoint. In making their ...
..., 2007--Treatment data from,Synovate Healthcare&rs...10,000 breast cancer patients in the UK could beco...lower death rates in,patients. The treatment was t...e edition of The Lancet (12 February 2007). Lower,...tched to the,aromotase inhibitor, Aromasin (exemes...
Other Medicine Technology:Icagen Terminates Phase III ASSERT Study 2Icagen Terminates Phase III ASSERT Study 3Over 10,000 UK Breast Cancer Patients Could Become Eligible Within,the Next Year for a Breast Cancer Therapy Showing Increased,Survival Rates, Reveals Synovate Healthcare’s European,Oncology Monitor 2Over 10,000 UK Breast Cancer Patients Could Become Eligible Within,the Next Year for a Breast Cancer Therapy Showing Increased,Survival Rates, Reveals Synovate Healthcare’s European,Oncology Monitor 3
...c diagnostic instrument that measures the refracti...e using a Hartmann-Shack wavefront sensor. The mea...-cylindrical) refractive errors and irregularities...on in the human eye. The WaveScan software uses th...
Zywave® II
ZYMAR™ 2.5 mL
REFRESH P.M.®
Medicine Products: